{
  "patientId": "MF001",
  "demographics": {
    "name": "Olivia Chen",
    "dob": "1968-07-11",
    "gender": "Female",
    "ageAtDiagnosis": "56 years old",
    "address": "101 Main St, Anytown, USA",
    "phone": "555-1010",
    "insurance": "Aetna",
    "referringPhysician": "Dr. Laura Davis (Dermatology)",
    "emergencyContact": "Mark Chen (Husband) - 555-1011"
  },
  "diagnosis": {
    "primary": "Mycosis Fungoides (MF)",
    "datePathologicDiagnosis": "03/01/2024 (Skin Biopsy)",
    "clinicalPresentation": "Widespread, thick plaques involving >50% BSA. Significant pruritus.",
    "tnmbStage": "T2b N0 M0 B0 (Stage IB)",
    "priorTreatmentSummary": "Failed topical steroids and narrowband UVB phototherapy.",
    "reasonForCurrentTreatment": "Extensive plaque-stage disease refractory to initial skin-directed therapies."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Samuel Green",
    "dermatologist": "Dr. Laura Davis",
    "treatmentSite": "Total Skin",
    "intent": "Disease control, Symptom relief (pruritus)",
    "modality": "Total Skin Electron Beam Therapy (TSEBT)",
    "totalDose": "36 Gy",
    "fractionation": "36 fx",
    "rtRxDetails": "36 Gy in 36 fractions (1 Gy/fx, 4x/week over 9 weeks)",
    "targetVolumeSummary": "Entire skin surface",
    "techniqueSummary": "Stanford Technique (6 dual fields)",
    "concurrentChemo": "None",
    "medications": [
      "Aggressive skin moisturization (e.g., Aquaphor)",
      "Topical steroids for localized reactions",
      "Antihistamines/Gabapentin for pruritus",
      "Monitor for skin infections"
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "01/20/2025",
      "setupInstructions": "Clinical simulation for TSEBT. Patient stands on a rotating platform at an extended distance from the machine. Patient holds various positions to expose all skin surfaces for the 6 dual fields (AP/PA, obliques).",
      "immobilization": "Standing position with support frame/straps.",
      "referenceMarks": "N/A (alignment is to room lasers and patient position, not tattoos).",
      "scanner": "N/A (Clinical setup)",
      "sliceThickness": "N/A",
      "contrastUsed": "N/A",
      "ctNotes": "Patient measured for dose calculations. Setup confirmed. In-vivo dosimetry (TLD/OSLD) placement locations determined to verify dose during treatment. Shielding for eyes and nails designed."
    },
    "dosimetry": {
      "planId": "OCMF001_TSEBT",
      "rx": "36 Gy / 36 fx",
      "technique": "TSEBT",
      "energy": "6 MeV",
      "numberOfFieldsOrArcs": 6,
      "gantryAngles": "Specific TSEBT angles (dual fields from two gantry angles)",
      "collAngles": "Open",
      "couchAngles": "Patient standing/rotating",
      "isoCoords": "Extended SSD setup",
      "tps": "Manual Calculation & Verification",
      "algorithm": "Manual/Measured Data",
      "hetero": "No",
      "norm": "Calibration Point",
      "constraints": "Lens dose minimized (<1 Gy) with external shields.",
      "planNotes": "Standard dose Stanford 6-field technique TSEBT. Shielding for eyes and nails to be used daily.",
      "fieldDetails": [
        { "fieldName": "AP/PA", "gantryAngle": "Dual Gantry Angles", "energy": "6 MeV", "monitorUnits": "Calibrated per session" },
        { "fieldName": "RAO/LPO", "gantryAngle": "Dual Gantry Angles", "energy": "6 MeV", "monitorUnits": "Calibrated per session" },
        { "fieldName": "LAO/RPO", "gantryAngle": "Dual Gantry Angles", "energy": "6 MeV", "monitorUnits": "Calibrated per session" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        { "fractionNumber": 8, "date": "2025-02-10", "machine": "LINAC 1 (TSEBT Mode)", "setupNotes":"Patient setup in all 6 positions. Shields in place. TLDs placed for weekly dose check.", "sideEffects": "Mild generalized erythema. Pruritus slightly improved.", "notes": "Tolerating daily setup well." },
        { "fractionNumber": 24, "date": "2025-03-10", "machine": "LINAC 1 (TSEBT Mode)", "setupNotes":"Setup consistent.", "sideEffects": "Moderate-severe erythema and patchy moist desquamation (Grade 2-3 dermatitis), particularly in skin folds. Significant fatigue.", "notes": "Managing skin reaction with prescribed creams. Pruritus much improved." }
      ]
    }
  },
  "imagingAndReports": [
    { "date": "03/01/2024", "type": "Skin Biopsy Report", "summary": "Mycosis Fungoides, patch/plaque stage. CD3+, CD4+, CD7-, CD8-.", "modalId": "oc-path-report", "reportDetails": { "lab": "Anytown Dermatopathology (Fictional Lab)", "patientInfo": "Chen, Olivia | ID: MF001 | DOB: 07/11/1968", "referringDoctor": "Dr. Laura Davis (Dermatology)", "pathNum": "D-24-7890", "dateObtained": "03/01/2024", "specimen": "Skin Punch Biopsy, Left Thigh Plaque", "diagnosis": "MYCOSIS FUNGOIDES, PATCH/PLAQUE STAGE.", "microscopicDescription": "Sections show band-like lymphocytic infiltrate in the papillary dermis with epidermotropism. Atypical lymphocytes with cerebriform nuclei are present singly and in small clusters within the epidermis (Pautrier's microabscesses). Dermal infiltrate consists predominantly of small to medium-sized lymphocytes with irregular nuclear contours. Immunohistochemical stains show the infiltrate is composed predominantly of CD3+, CD4+ T-cells with partial loss of CD7. CD8 highlights scattered reactive T-cells. CD20 is negative.", "comment": "Histologic and immunophenotypic findings are consistent with Mycosis Fungoides.", "signedBy": "Dr. D. Path Fictional, 03/03/2024" } },
    { "date": "01/10/2025", "type": "Clinical Photos", "summary": "Widespread plaques involving >50% BSA.", "modalId": "oc-clinical-photos", "reportDetails": { "fullSummary": "Photographs document widespread erythematous, indurated plaques covering estimated 50-60% of body surface area. Involvement noted on trunk, upper and lower extremities. Some scaling and excoriations noted, consistent with pruritus.", "imageSrc": "https://placehold.co/600x400/EEE/31343C?text=Clinical+Photos+MF" } },
    { "date": "01/15/2025", "type": "CT Chest/Abdomen/Pelvis", "summary": "No evidence of extracutaneous disease.", "modalId": "oc-ct-staging", "reportDetails": { "findings": "No definite evidence of thoracic, abdominal, or pelvic lymphadenopathy. Liver and spleen are normal in size. Lungs are clear. No suspicious osseous lesions.", "impression": "No CT evidence of extracutaneous disease.", "imageSrc": "https://placehold.co/500x500/DDD/525252?text=Staging+CT+Scan" } },
    { "date": "01/20/2025", "type": "TSEBT Simulation/Dosimetry Note", "summary": "Patient measured, setup confirmed. Dose calculations performed. Shielding designed.", "modalId": "oc-tsebt-sim", "reportDetails": { "procedure": "Simulation for Total Skin Electron Beam Therapy.", "setup": "Patient positioned standing using Stanford technique setup (6 dual fields: AP/PA, LAO/RPO, RAO/LPO). Patient able to maintain positions.", "dosimetry": "In-vivo dosimetry planned using TLDs/OSLDs placed at multiple body sites (scalp, chest, axilla, groin, soles) to verify dose delivery during treatment.", "shielding": "Custom eye shields fabricated. Plan for shielding of fingernails and toenails with lead strips.", "notes": "Patient instructed on positioning and need to remain still during treatment. Procedure explained and tolerated.", "imageSrc": "https://placehold.co/600x300/BBB/708090?text=TSEBT+Setup+Diagram" } }
  ],
  "dicomImages": [],
  "labResults": [
    { "date": "01/15/2025", "test": "CBC", "value": "WNL", "notes": "Pre-TSEBT Baseline" },
    { "date": "01/15/2025", "test": "CMP", "value": "WNL", "notes": "Pre-TSEBT Baseline" },
    { "date": "01/15/2025", "test": "LDH", "value": "WNL", "notes": "Pre-TSEBT Baseline" },
    { "date": "01/15/2025", "test": "Sézary Count (Flow Cytometry)", "value": "<250 cells/µL (B0)", "notes": "No significant blood involvement" }
  ],
  "progressNotes": [
    { "date": "01/05/2025", "author": "Dr. Laura Davis (Derm)", "type": "Referral Note", "summary": "56yo F with Stage IB MF, extensive plaques (>50% BSA). Failed topical steroids and NB-UVB. Significant pruritus impacting QOL. Refer to Rad Onc for TSEBT consideration." },
    { "date": "01/18/2025", "author": "Dr. Samuel Green (Rad Onc)", "type": "Initial Consult", "summary": "Pt referred for TSEBT for refractory Stage IB MF. Exam confirms widespread thick plaques. Staging workup negative for extracutaneous disease. Discussed TSEBT procedure (Stanford technique, 36Gy/36fx over 9 wks), expected toxicities (significant dermatitis, fatigue, hair loss, nail changes), and goals (disease control, symptom improvement). Pt understands and wishes to proceed. Sim scheduled." },
    { "date": "01/20/2025", "author": "Nursing/RT Ed", "type": "TSEBT Education", "summary": "Detailed skin care instructions provided (moisturizing, gentle cleansing, managing desquamation). Shielding explained. Schedule reviewed. Supportive care resources discussed." },
    { "date": "02/10/2025", "author": "Dr. Samuel Green (Rad Onc)", "type": "OTV - Week 2", "summary": "Completed 8/36 fx. Mild generalized erythema developing. Pruritus slightly improved. Tolerating daily setup well. Continue TSEBT. Reinforce skin care." },
    { "date": "03/10/2025", "author": "Dr. Samuel Green (Rad Onc)", "type": "OTV - Week 6", "summary": "Completed 24/36 fx. Moderate-severe erythema and patchy moist desquamation (Grade 2-3 dermatitis), particularly in skin folds. Managing with topical steroids/creams. Fatigue significant. Pruritus much improved. Continue TSEBT with close skin monitoring." }
  ],
  "patientEducation": {
    "goalsDiscussed": "Control widespread skin disease (Mycosis Fungoides) and relieve severe itching.",
    "sideEffectsReviewed": "A significant, whole-body skin reaction is expected (like a severe, prolonged sunburn) with redness, dryness, peeling, and possibly blistering. Total hair loss (head and body) is expected but usually temporary. Nail changes (lifting, loss) are possible. Significant fatigue is very common.",
    "safetyConsiderations": "Meticulous, intensive skin care is required (frequent moisturizing, gentle cleansing). High risk of skin infection. Shielding will be used to protect eyes and nails.",
    "patientResponsibilities": "Attend long course of daily treatments (4x/week for 9 weeks). Adhere strictly to skin care regimen. Report any signs of infection (fever, pus) immediately.",
    "medicationCompliance": "Use topical creams and anti-itch medications as prescribed."
  },
  "scheduling": [
    { "date": "01/15/2025", "time": "9 AM", "type": "Staging CT C/A/P", "location": "Radiology", "status": "Completed" },
    { "date": "01/18/2025", "time": "10 AM", "type": "Rad Onc Consult (Green)", "location": "Rad Onc Clinic", "status": "Completed" },
    { "date": "01/20/2025", "time": "1 PM", "type": "TSEBT Simulation", "location": "Rad Onc Sim", "status": "Completed" },
    { "date": "01/27/2025 - ~03/31/2025", "time": "Daily (M,Tu,Th,F) ~9 AM", "type": "TSEBT Treatment (1/36)", "location": "LINAC 1 (TSEBT Mode)", "status": "Ongoing" },
    { "date": "Weekly", "time": "~9:30 AM (Post-RT)", "type": "OTV / Skin Check", "location": "Rad Onc Clinic", "status": "Scheduled" }
  ],
  "cptCharges": [
    { "code": "77285 / 77290", "description": "Simulation, Intermediate / Complex", "frequency": "Once" },
    { "code": "77334", "description": "Treatment device, Complex (Shielding blocks)", "frequency": "Once per course" },
    { "code": "77300", "description": "Basic radiation dosimetry calculation (TLD measurements)", "frequency": "Weekly/Per Course" },
    { "code": "77331", "description": "Special physics consultation (TSEBT planning)", "frequency": "Once" },
    { "code": "77422", "description": "Total skin electron therapy", "frequency": "Per Session (Daily)" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "Weekly" }
  ],
  "diagnosisSearch": "Mycosis Fungoides"
}